Catabasis Pharma (CATB) Earnings
|
Expand Research on CATB
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -10.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/10/20 |  |
Q419 | -$0.55 | -$0.61 | +$0.06 | N/A | N/A | N/A |  | | Details |
| 11/7/19 | |
Q319 | -$0.56 | -$0.64 | +$0.08 | N/A | N/A | N/A | | | Details |
| 8/8/19 | |
Q219 | -$0.62 | -$0.61 | -$0.01 | N/A | N/A | N/A | | | Details |
| 5/14/19 | |
Q119 | -$0.62 | -$0.69 | +$0.07 | N/A | N/A | N/A | | | Details |
| 3/14/19 | |
Q418 | -$0.85 | -$0.90 | +$0.05 | N/A | N/A | N/A | | | Details |
| 11/13/18 | |
Q318 | -$0.08 | N/A | N/A | N/A | N/A | N/A | | | Details |
| 8/9/18 | |
Q218 | -$0.20 | -$0.23 | +$0.03 | N/A | N/A | N/A | | | Details |
| 5/10/18 | |
Q118 | -$0.29 | -$0.20 | -$0.09 | N/A | $130K | = | | | Details |
